Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.50
+0.13 (0.90%)
May 22, 2026, 9:31 AM EDT - Market open
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $542.1 million as of May 22, 2026. Its market cap has increased by 425.15% in one year.
Market Cap
542.10M
Enterprise Value
297.87M
1-Year Change
425.15%
Ranking
Category
Stock Price
$14.50
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $542.10M, an increase of 34.82%. That is a compound annual growth rate of 15.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 537.24M | 28.67% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 514.94M |
| Forte Biosciences | 490.42M |
| Prime Medicine | 487.67M |
| Ginkgo Bioworks Holdings | 480.79M |
| Prothena Corporation | 474.84M |
| Immix Biopharma | 469.69M |
| ProKidney | 468.04M |
| Climb Bio | 460.97M |